Selection and preference for botulinum toxins in the management of photoaging and facial lines: patient and physician considerations

References

• PetrusGMLewisDMaasCSAnatomic considerations for treatment with botulinum toxinFacial Plast Surg Clin North Am200711917317550
   PubMedGoogle Scholar
• WardABMolenaersGColosimoCBerardelliAClinical value of botulinum toxin in neurological indicationsEur J Neurol20064202617112346
   PubMed Web of Science ®Google Scholar
• CarruthersJDACarrutherJATreatment of glabellar frown lines with C. botulinum A exotoxinJ Dermatol Surg Oncol19911817211740562
   PubMedGoogle Scholar
• LoweNJAscherBHeckmannMKumarCFraczekSEadieNBotox Facial Aesthetics Study TeamDouble-blind, randomized, placebo-controlled, dose-response study of the safety and efficacy of botulinum toxin type A in subjects with crow’s feetDermatol Surg200531325726215841623
   PubMed Web of Science ®Google Scholar
• CarruthersACarruthersJA single-center, dose-comparison, pilot study of botulinum neurotoxin type A in female patients with upper facial rhytids: safety and efficacyJ Am Acad Dermatol200960697297919467368
   PubMed Web of Science ®Google Scholar
• LoweNJYamauchiPSLaskGPPatnaikRMooreDBotulinum toxins types A and B for brow furrows: preliminary experiences with type B toxin dosingJ Cosmet Laser Ther200241151812079632
   PubMedGoogle Scholar
• SpencerJMGordonMGoldbergDJBotulinum B treatment of the glabellar and frontalis regions: a dose response analysisJ Cosmet Laser Ther200241192312079633
   PubMedGoogle Scholar
• SadickNSFaacsBotulinum toxin type B for glabellar wrinkles: a prospective open-label response studyDermatol Surg200228981782112269875
   PubMed Web of Science ®Google Scholar
• MatarassoSLComparison of botulinum toxin types A and B: a bilateral and double-blind randomized evaluation in the treatment of canthal rhytidesDermatol Surg200329171312534505
   PubMed Web of Science ®Google Scholar
• SadickNSHermanARComparison of botulinum toxins A and B in the aesthetic treatment of facial rhytidesDermatol Surg200329434034712656810
   PubMed Web of Science ®Google Scholar
• SadickNSBotulinum toxin type BDermatol Surg200329434835012656811
   PubMed Web of Science ®Google Scholar
• SadickNSProspective open-label study of botulinum toxin type B (Myobloc) at doses of 2,400 and 3,000 U for the treatment of glabellar wrinklesDermatol Surg200329550150712752518
   PubMed Web of Science ®Google Scholar
• BaumannLSlezingerAVujevichJHalemMBrydeJBlackLDuncanRA double-blinded, randomized, placebo-controlled pilot study of the safety and efficacy of Myobloc (botulinum toxin type B)-purified neurotoxin complex for the treatment of crow’s feet: a double-blinded, placebo-controlled trialDermatol Surg200329550851512752519
   PubMed Web of Science ®Google Scholar
• SchantzEJHistorical perspectiveJankovicJHalletMTherapy with botulinum toxinNew YorkMarcel Dekker, Inc1994xxiiixxvi
   Google Scholar
• CoffieldJAConsidineRVSimpsonLLThe site and mechanism of action of botulinum neurotoxinJankovicJHalletMTherapy with botulinum toxinNew YorkMarcel Dekker, Inc1994313
   Google Scholar
• MartinTFJStages of regulated exocytosisTrends Cell Biology19977271276
   Web of Science ®Google Scholar
• BlasiJChapmanERLinkEBotulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25Nature199336564421601638103915
   PubMed Web of Science ®Google Scholar
• SchiavoGBenfenatiFPoulainBTetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevinNature19923598328351331807
   PubMed Web of Science ®Google Scholar
• AlamMDoverJSArndtKAPain associated with injection of botulinum A exotoxin reconstituted using isotonic sodium chloride with and without preservative: a double-blind, randomized controlled trialArch Dermatol2002138451051411939813
   PubMedGoogle Scholar
• YomtoobDEDewanMALeeMSHarrisonARComparison of pain scores with 30-gauge and 32-gauge needles for periocular botulinum toxin type a injectionsOphthal Plast Reconstr Surg2009255376377
   PubMed Web of Science ®Google Scholar
• FrankelASMarkarianACosmetic treatments and strategies for the upper faceFacial Plast Surg Clin North Am2007151313917317553
   PubMedGoogle Scholar
• CarruthersJALoweNJMenterMABotox Glabellar Lines I Study GroupA multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar linesJ Am Acad Dermatol200246684084912063480
   PubMed Web of Science ®Google Scholar
• MaasCSKimEJTemporal brow lift using botulinum toxin A: an updatePlast Reconstr Surg2003112S109S112
   Google Scholar
• RedaelliAForteRHow to avoid brow ptosis after forehead treatment with botulinum toxinJ Cosmet Laser Ther200353–422022214741838
   PubMedGoogle Scholar
• LoweNJShahALowePlPatnaikRDosing, efficacy and safety plus the use of computerized photography for botulinum toxins type A for upper facial linesJ Cosmet Laser Ther201012210611120151785
   PubMed Web of Science ®Google Scholar
• TamuraBMOdoMYChangBCucéLCFlynnTCTreatment of nasal wrinkles with botulinum toxinDermatol Surg200531327127515841625
   PubMed Web of Science ®Google Scholar
• SemchyshynNSengelmannRDBotulinum toxin A treatment of perioral rhytidesDermatol Surg200329549049512752516
   PubMed Web of Science ®Google Scholar
• FlynnTCUpdate on botulinum toxinSemin Cutan Med Surg200625311512117055389
   PubMed Web of Science ®Google Scholar
• MatarassoAMatarassoSLBotulinum A exotoxin for the management of platysma bandsPlast Reconstr Surg2003112S138S140
   Google Scholar
• HexselDSpencerJMWoolery-LloydHGilbertEPractical applications of a new botulinum toxinJ Drugs Dermatol20109S31S3720361474
   PubMed Web of Science ®Google Scholar
• WohlfarthKSychaTRanouxDNaverHCairdDDose equivalence of two commercial preparations of botulinum neurotoxin type A: time for a reassessment?Curr Med Res Opin20092571573158419463043
   PubMed Web of Science ®Google Scholar
• LowePPatnaikRLoweNComparison of two formulations of botulinum toxin type A for the treatment of glabellar lines: a double-blind, randomized studyJ Am Acad Dermatol200655697598017097394
   PubMed Web of Science ®Google Scholar
• BaumannLBrandtFKaneMAn analysis of efficacy data from five phase III studies of BoNT-A for the treatment of glabellar linesJ Am Acad Dermatol2010623AB40
   Web of Science ®Google Scholar
• AscherBRzanyBJGroverREfficacy and safety of botulinum toxin type A in the treatment of lateral crow’s feet: double-blind, placebo-controlled, dose-ranging studyDermatol Surg200935101478148619686365
   PubMed Web of Science ®Google Scholar
• AlsterTSLuptonJRBotulinum toxin type B for dynamic glabellar rhytides refractory to botulinum toxin type ADermatol Surg200329551651812752520
   PubMed Web of Science ®Google Scholar
• YamauchiPSLoweNJBotulinum toxin types A and B: comparison of efficacy, duration, and dose-ranging studies for the treatment of facial rhytides and hyperhidrosisClin Dermatol2004221343915158543
   PubMed Web of Science ®Google Scholar
• CarruthersJALoweNJMenterMABotox Glabellar Lines I Study GroupA multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar linesJ Am Acad Dermatol200246684084912063480
   PubMed Web of Science ®Google Scholar
• ChengCMCosmetic use of botulinum toxin type A in the elderlyClin Interv Aging200721818318044078
   PubMed Web of Science ®Google Scholar
• RhodesLMNormanRHWroneDACutaneous surgery in the elderly: ensuring comfort and safetyDermatol Ther20031624325314510881
   PubMedGoogle Scholar
• CarruthersJFagienSMatarassoSLConsensus recommendations on the use of botulinum toxin type A in facial aestheticsPlast Reconstr Surg2004114S1S22
   PubMed Web of Science ®Google Scholar
• de AlmeidaATDe BoulleKDiffusion characteristics of botulinum neurotoxin products and their clinical significance in cosmetic applicationsJ Cosmet Laser Ther20079172217885882
   PubMedGoogle Scholar
• BorodicGMyasthenic crisis after botulinum toxinLancet199835291431832
   Web of Science ®Google Scholar
• SchaffnerRKreydenOPComplications and side-effects of botulinum toxin ACurr Probl Dermatol20023014114812471708
   PubMedGoogle Scholar
• KleinAWComplications with the use of botulinum toxinDermatol Clin200422219720515222580
   PubMed Web of Science ®Google Scholar
• CarruthersACarruthersJPatient-reported outcomes with botulinum neurotoxin type AJ Cosmet Laser Ther20079323717885884
   PubMedGoogle Scholar
• FagienSCoxSEFinnJCWerschlerWPKowalskiJWPatient-reported outcomes with botulinum toxin type A treatment of glabellar rhytids: a double-blind, randomized, placebo-controlled studyDermatol Surg200733S2S917241410
   PubMed Web of Science ®Google Scholar
• CarruthersJCarruthersABotulinum toxin type A treatment of multiple upper facial sites: patient-reported outcomesDermatol Surg200733S10S1717241408
   PubMed Web of Science ®Google Scholar
• LewisMBBowlerPJBotulinum toxin cosmetic therapy correlates with a more positive moodJ Cosmet Dermatol200981242619250162
   PubMed Web of Science ®Google Scholar